Acipimox inhibits human carbonic anhydrases
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.1080/14756366.2022.2037579
Abstract: Abstract Acipimox, a nicotinic acid derivative in clinical use for the treatment of hyperlipidaemia, incorporates a free carboxylic acid and an N-oxide moiety, functionalities known to interact with the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1)… read more here.
Keywords: human carbonic; acipimox inhibits; carbonic anhydrases; chemistry ... See more keywords